SCHEMBL7989420

SCHEMBL7989420

Oc1nc(-c2cccnc2)nc2ncn(Cc3ccc(F)cc3)c12

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MET P08581 1/20 0.45
CYP11B1 P15538 1/20 0.43
CYP11B2 P19099 1/20 0.43
POLB P06746 1/20 0.42
ABCG2 Q9UNQ0 2/20 0.41
MAPT P10636 5/20 0.41
TP53 P04637 1/20 0.41
KDM4E B2RXH2 1/20 0.40
CYP1A2 P05177 1/20 0.40
CYP3A4 P08684 1/20 0.40
HPGD P15428 1/20 0.40
TSHR P16473 1/20 0.40
MAPK1 P28482 1/20 0.40
CYP2C19 P33261 1/20 0.40
HSD17B10 Q99714 1/20 0.40
TDP1 Q9NUW8 1/20 0.40
DHPS P49366 1/20 0.40
KLKB1 P03952 4/20 0.40
SMN1; SMN2 Q16637 2/20 0.40
F2 P00734 2/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7974286 0.90 DHPS (0.49) CYP11B1CYP11B2POLBABCG2MAPT
SCHEMBL7984769 0.89 CLK4 (0.44) CYP11B1CYP11B2ABCG2MAPTTP53
SCHEMBL7985334 0.89 ABCG2 (0.46) CYP11B1CYP11B2ABCG2KDM4EDHPS
SCHEMBL7986521 0.88 CYP11B1 (0.47) METCYP11B1CYP11B2MAPTTP53
SCHEMBL7985275 0.86 MET (0.46) METCYP11B1CYP11B2HDAC6
SCHEMBL7974237 0.86 KIF11 (0.42) ABCG2MAPTTP53KDM4EDHPS
SCHEMBL7984281 0.86 MET (0.52) METCYP11B1CYP11B2KDM4ESMN1; SMN2
SCHEMBL7988734 0.84 MET (0.44) METCYP11B1CYP11B2ABCG2KDM4E
SCHEMBL7988659 0.84 P2RX7 (0.41) CYP11B1CYP11B2ABCG2MAPTCYP3A4
SCHEMBL7985118 0.84 ADRB2 (0.41) POLBABCG2MAPTTP53KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6310070-B1 FOR TREATING NEPHRITIS, IMPROVING PROTEINURIA DUE TO GLOMERULONEPHRITIS AND PREVENTING AGGRAVATION OF NEPHRITIS JAPAN ENERGY CORPORATION (JP) 2001-10-30 US disclosed
EP-0999211-A1 NOVEL PURINE DERIVATIVES AND MEDICINAL USE THEREOF JAPAN ENERGY CORPORATION (JP) 2000-05-10 EP disclosed